Tilray Inc (TLRY : TSX)
Common Stock
$6.15
CAD
-0.15 (-2.38%)
Last updated: 2026-07-14
TLRY
Tilray Inc
WealthAwesomePerformance
1 Day
-2.38%
1 Week
+0.65%
1 Month
-11.64%
YTD
-53.93%
Key Statistics
Market Cap
$777.78M
52W High
$32.30
52W Low
$5.98
P/E Ratio
-
50 Day MA
$7.12
200 Day MA
$7.82
Beta
1.90
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/14/2026 | $6.25 | $6.33 | $6.00 | $6.15 | $6.15 | 387,254 |
| 7/13/2026 | $6.24 | $6.47 | $6.17 | $6.30 | $6.30 | 641,076 |
| 7/10/2026 | $6.28 | $6.41 | $6.19 | $6.23 | $6.23 | 401,292 |
| 7/9/2026 | $6.23 | $6.30 | $6.11 | $6.21 | $6.21 | 369,342 |
| 7/8/2026 | $6.08 | $6.29 | $5.98 | $6.22 | $6.22 | 568,173 |
| 7/7/2026 | $6.22 | $6.31 | $6.05 | $6.11 | $6.11 | 378,554 |
| 7/6/2026 | $6.56 | $6.60 | $6.20 | $6.23 | $6.23 | 520,634 |
| 7/3/2026 | $6.53 | $6.58 | $6.46 | $6.52 | $6.52 | 258,726 |
| 7/2/2026 | $6.41 | $6.87 | $6.40 | $6.56 | $6.56 | 781,998 |
| 6/30/2026 | $6.52 | $6.54 | $6.33 | $6.38 | $6.38 | 409,127 |
Analyst Price Targets
Based on analyst covering TLRY
Wall Street analysts forecast TLRY stock price to rise 32.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$8.12
+32.1% Upside
Current Price
C$6.15
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TLRY's historical volatility
30-Day Vol
35.3%
Annualized
90-Day Vol
54.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$5.14
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$5.79 | C$5.13 – C$6.54 |
| 60 trading days | C$5.46 | C$4.60 – C$6.49 |
| 90 trading days | C$5.14 | C$4.17 – C$6.35 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Tilray Inc
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Cruisies, Atwater Brewery, Hiball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company, SweetWater Brewing Company, Terrapin Beer Co., Happy Flower, Fizzy Jane's, Herb & Bloom, 420 Fizz, and Fresh Hemp Foods brands. The company sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Financials
- Revenue (TTM)
- $858.28M
- EBITDA
- $17.76M
- Profit Margin
- -156.66%
- ROE (TTM)
- -63.16%
- EPS (Diluted)
- -20.77
- Book Value
- 4.29
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
🔄 Recent Splits
1-for-10
Dec 2, 2025
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About TLRY
Articles Featuring TLRY.TO
Latest articles and analysis covering TLRY.TO
Why Tilray Inc stock is sliding today
Tilray Inc's stock dropped 3.17% in today's trading session, closing at CA$6.10. This decline highlights the ongoing volatility within the cannabis market, despite the company’s recent record revenue announcements.
Why Tilray Inc stock is sliding today
Tilray Inc's stock price fell by 3.99% today, closing at CA$6.26. Despite reporting strong revenues in recent quarters, the market reaction suggests investor caution regarding its profitability and growth potential.
Why Tilray Inc stock is tanking today
Tilray Inc's stock fell 1.22% in the last session, closing at CA$6.48. Investors are left wondering about the company's direction as it navigates a competitive market with limited recent news.
Why Tilray Inc stock is sliding today
Tilray Inc's stock slid by 2.74% in the last trading session, closing at CA$6.38. This decline raises questions about the company's ability to navigate current market challenges, despite its ambitious growth plans.
Why Tilray Inc stock is sliding today
Tilray Inc's stock slid by 3.05% today, closing at CA$6.36. Investors are wary as the company navigates recent financial results and a planned reverse stock split.
Why Tilray Inc stock is rising today
Tilray Inc's stock has risen by 3.47% following the release of strong first-quarter fiscal results, showcasing the company's commitment to profitability and operational efficiency.
Why Tilray Inc stock is sliding today
Tilray Inc's stock slid 3.65% today, closing at CA$6.34. This downturn raises questions about the company's future in a volatile cannabis market, despite recent positive revenue reports.
Why Tilray Inc stock is sliding today
Tilray Inc's stock slid by 4.10% today, closing at CA$6.31. This decline raises questions about the company's future in a volatile cannabis market, despite recent reports of strong revenue growth.
Why Tilray Inc stock is tanking today
Tilray Inc's stock has dropped 1.75% in the last session, despite the company reporting record revenues. This decline raises questions about investor confidence in the cannabis market's stability.
Why Tilray Inc stock is tanking today
Tilray Inc's stock fell 1.54% today, closing at CA$7.02. This decline raises concerns about the company's financial health and market strategy as it navigates a competitive landscape.
Why Tilray Inc stock is rising today
Tilray Inc's stock rose by 2.71% in the last trading session, closing at CA$7.19. This uptick is supported by the company's recent financial performance, showcasing organic growth and resilience in a challenging market.
Why Tilray Inc stock is gaining today
Tilray Inc's stock gained 1.60% today, closing at CA$7.00. This increase aligns with the company's ongoing growth strategies and upcoming financial announcements.
